Elixir Capital Limited Schedules Q2 FY27 Results for November 6

Elixir Capital will consider its unaudited Q2 and half-year FY27 financial results on November 6, 2026, after reporting revenue of ₹20.62 crore for the quarter ended June 2026. The board meeting will provide the company’s first reported update for the September quarter and the first half of FY27.

When will Elixir Capital announce its Q2 FY27 results?

Elixir Capital’s board is scheduled to meet on November 6, 2026, to consider unaudited financial results for the quarter and half year ended September 30, 2026. The disclosure places the company among listed firms reporting September-quarter earnings during the ongoing Q2 FY27 results season.

The company had earlier communicated the closure of its trading window from October 1, 2026. The closure applies ahead of the release of the unaudited quarterly and half-year numbers and is intended to restrict dealings in the company’s securities by designated persons during the results period.

The September-quarter statement will be significant because it will show whether the performance recorded in the June quarter continued into the following three months. It will also provide half-year figures that allow investors to assess the company’s FY27 performance over the April-to-September period.

What did Elixir Capital report in the June 2026 quarter?

Elixir Capital reported revenue of ₹20.62 crore and net profit of ₹8.30 crore for the quarter ended June 2026, or Q1 FY27, according to the supplied earnings information. The reported revenue was substantially above the ₹11 crore revenue shown for the June 2025 quarter in the quarterly data provided.

Another set of Q1 FY27 figures in the supplied material states that net profit rose 124.91% year on year to ₹6.14 crore and increased 213.08% sequentially. The source material therefore contains differing net-profit figures for the June quarter. Investors should rely on the company’s filed financial statements and exchange disclosures when comparing quarterly profitability.

The quarterly financial data also shows sales of ₹20.42 crore and operating profit of ₹12.77 crore for June 2026. The small difference between this sales figure and the separately stated ₹20.62 crore revenue figure reflects the way data has been presented across the supplied sources, rather than a basis for calculating a new metric.

Why did Elixir Capital’s FY26 earnings decline?

Elixir Capital’s consolidated revenue declined to ₹34.21 crore in FY26 from ₹41.34 crore in the preceding year. Consolidated net profit fell to ₹3.03 crore from ₹9.33 crore. The annual report attributed the decline mainly to weak market conditions in the second half of the year and startup costs associated with the launch of the fintech division.

Separate AGM-related information said FY26 profit declined from ₹18.02 crore to ₹5.31 crore because of geopolitical events. The figures in the supplied material appear to refer to different reporting bases or disclosures. The annual report’s consolidated figures provide the stated comparison for consolidated revenue and profit.

The company’s annual report also referred to initiatives including a mutual fund chatbot on WhatsApp and growth in the PaisaSmart YouTube channel. It highlighted a focus on small- and mid-cap stocks for FY27. These initiatives form part of the company’s operating context, although the supplied information does not quantify their contribution to revenue or earnings.

How could the Q2 disclosure matter to investors?

The Q2 and H1 FY27 release will give investors updated reported figures on revenue, profitability and operating performance after the June-quarter revenue increase. It will also offer a basis to compare the September period with the earlier quarter and with the corresponding period of the previous year, subject to the accounting basis used in the final filing.

The trading-window closure means designated persons are restricted from dealing in Elixir Capital securities during the specified results-related period. Once results are released and the trading window reopens in line with the company’s code and applicable requirements, the market will have access to the financial disclosure that was pending during the restricted period.

For the broader financial-services sector, the results are relevant because Elixir Capital has identified market conditions as a factor behind FY26 performance. Its September-quarter numbers may show how its operations performed after a year in which weak second-half markets and fintech startup costs affected consolidated earnings.

What should be assessed in the September-quarter results?

Investors can assess whether revenue remained above the June-quarter level of ₹20.62 crore, how net profit compares with the company’s reported Q1 figures, and whether any commentary addresses the FY26 pressure from market conditions and fintech startup costs. The half-year results will be particularly useful because they combine the June and September quarters.

The company’s disclosures on its fintech division, digital initiatives and small- and mid-cap market focus will also be relevant where management provides quantified updates. The available information does not state a financial target for FY27, so any assessment should remain tied to the reported results, accompanying notes and management commentary.

Conclusion

Elixir Capital’s November 6 board meeting is the scheduled point for its Q2 and first-half FY27 financial update. The announcement follows a June quarter in which revenue was reported at ₹20.62 crore, while FY26 consolidated revenue and profit had declined to ₹34.21 crore and ₹3.03 crore, respectively.

The next item to watch is the unaudited September-quarter and half-year filing, including any reconciliation of performance measures, management comments on market conditions and details of fintech-related costs or progress. The company has disclosed the meeting date, but no Q2 FY27 financial figures were included in the supplied information.